Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer PR Newswire OSLO, Norway, Feb. 28, 2022 OSLO, Norway, Feb. 28...
Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway PR Newswire OSLO, Norway, Jan. 12, 2022 OSLO, Norway, Jan. 12, 2022...
Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma PR Newswire OSLO, Norway, Dec. 20, 2021 The...
Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma The median overall survival (mOS) was 25.0 months...
Targovax ASA: Third quarter 2021 results PR Newswire OSLO, Norway, Nov. 4, 2021 OSLO, Norway, Nov. 4, 2021 /PRNewswire/ -- Targovax ASA (OSE:...
Targovax: Presentation material for today's webcast PR Newswire OSLO, Norway, Oct. 25, 2021 OSLO, Norway, Oct. 25, 2021 /PRNewswire/ -- Targovax...
Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO PR Newswire OSLO, Norway, Oct. 20, 2021 OSLO, Norway, Oct. 20, 2021 /PRNewswire/...
Targovax to present at upcoming conferences PR Newswire OSLO, Norway, Oct. 19, 2021 OSLO, Norway, Oct. 19, 2021 /PRNewswire/ -- Targovax...
Targovax ASA: Two abstracts accepted at the SITC Congress PR Newswire OSLO, Norway, Oct. 6, 2021 OSLO, Norway, Oct. 6, 2021 /PRNewswire/...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관